Greenwich LifeSciences (GLSI) Short Interest Ratio & Short Volume

Greenwich LifeSciences logo
$13.76 -1.18 (-7.90%)
Closing price 11/16/2026 04:00 PM Eastern
Extended Trading
$13.68 -0.08 (-0.58%)
As of 04:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Greenwich LifeSciences Short Interest Overview

As of October 30, 2026, Greenwich LifeSciences (GLSI) had a short interest of 1.58 million shares sold short, representing 22.07% of the public float. This marks a 1.66% increase in short interest since the prior report. The short interest ratio (days to cover) is 12.5, meaning it would take 12.5 days of the average trading volume of 130,920 shares to cover all short positions.

Current Short Interest
1,578,166 shares
Previous Short Interest
1,552,366 shares
Change Vs. Previous Report
1.66%
Dollar Volume Sold Short
$27.48 million
Short Interest Ratio
12.5 Days to Cover
Last Record Date
October 30, 2026
Outstanding Shares
14,680,000 shares
Short Percent of Float
22.07%
Today's Trading Volume
153,544 shares
Average Trading Volume
130,920 shares
Today's Volume Vs. Average
117%
Short Selling Greenwich LifeSciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Greenwich LifeSciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

GLSI Short Interest Over Time

GLSI Days to Cover Over Time

GLSI Percentage of Float Shorted Over Time

Greenwich LifeSciences Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/30/20261,578,166 shares $27.48 million +1.7%22.1%12.51 $17.41
10/15/20261,552,366 shares $23.78 million -1.8%21.8%10.71 $15.32
9/30/20261,580,950 shares $28.54 million -3.1%22.2%11.38 $18.05
9/15/20261,631,150 shares $26.25 million -1.8%22.9%19.78 $16.09
8/31/20261,660,969 shares $24.83 million +4.2%23.3%11.35 $14.95
8/14/20261,593,720 shares $26.77 million +3.4%22.4%13.27 $16.80
7/31/20261,541,345 shares $20.81 million +5.0%21.6%7.18 $13.50
7/15/20261,467,739 shares $28.68 million +0.7%20.6%12.12 $19.54
6/30/20261,458,039 shares $34.21 million -0.2%20.5%8.63 $23.46
6/15/20261,461,511 shares $34.21 million -3.7%20.5%9.02 $23.41
5/29/20261,518,228 shares $39.73 million -1.5%21.3%13.37 $26.17
5/15/20261,541,786 shares $41.95 million -0.2%22.9%11.02 $27.21
4/30/20261,544,439 shares $36.48 million +1.4%23.0%10.97 $23.62
4/15/20261,522,683 shares $39.45 million +1.3%21.4%13.05 $25.91
3/31/20261,503,361 shares $36.11 million +5.9%21.1%7.46 $24.02
3/13/20261,419,597 shares $37.96 million +6.1%21.1%9.03 $26.74
2/27/20261,337,470 shares $37.07 million +4.5%19.9%10.11 $27.72
2/13/20261,280,298 shares $34.38 million -2.9%18.0%5.81 $26.85
1/30/20261,318,481 shares $39.65 million -14.7%19.6%1.32 $30.07
1/15/20261,546,371 shares $42.05 million -7.4%23.0%3.41 $27.19
12/31/20251,669,533 shares $35.08 million +3.1%24.8%1.83 $21.01
12/15/20251,619,259 shares $16.69 million +0.6%24.1%3.68 $10.31
11/28/20251,610,157 shares $14.26 million +1.7%23.9%27.34 $8.86
11/14/20251,582,602 shares $13.17 million +17.6%23.5%14.03 $8.32
10/31/20251,346,362 shares $12.40 million +0.3%20.0%19.89 $9.21
10/15/20251,340,000 shares $13.84 million -2.2%21.9%20.8 $10.33
9/30/20251,370,000 shares $13.63 million +11.4%22.4%19.4 $9.95
9/15/20251,230,000 shares $14.37 million +15.0%20.1%18.4 $11.68
8/31/20251,070,000 shares $12.28 million +0.9%17.5%18.2 $11.48
8/15/20251,060,000 shares $12.90 million +1.9%17.4%19.7 $12.17
7/31/20251,040,000 shares $11.38 million +4.0%17.4%20 $10.94
7/15/20251,000,000 shares $10.08 million -2.9%16.7%17.5 $10.08
6/30/20251,030,000 shares $9.34 million +6.3%17.2%16.1 $9.07
6/15/2025968,600 shares $8.91 million +0.9%16.2%12.5 $9.20
5/31/2025959,900 shares $9.42 million -5.0%16.0%12.6 $9.81
5/15/20251,010,000 shares $9.79 million +1.2%16.9%13.7 $9.69
4/30/2025998,000 shares $10.08 million +9.6%16.8%14.1 $10.10
4/15/2025910,700 shares $8.15 million +22.5%15.3%13.1 $8.95
3/31/2025743,300 shares $7.09 million +12.9%12.6%12.4 $9.54
3/15/2025658,400 shares $7.90 million +2.3%11.1%19.8 $12.00
Your $7 scanner is waiting (Ad)

The Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.tc pixel

Get the Instant Scanner for $7 in the Black Friday sale today.
2/28/2025643,500 shares $7.86 million -1.5%10.9%21 $12.22
2/15/2025653,100 shares $8.09 million +1.4%11.1%20 $12.38
1/31/2025644,000 shares $8.33 million +5.1%10.9%19.1 $12.94
1/15/2025612,700 shares $7.64 million +10.1%10.4%17.8 $12.47
12/31/2024556,700 shares $6.25 million +5.0%9.4%18.3 $11.23
12/15/2024530,200 shares $7.16 million +8.1%9.0%18.8 $13.51
11/30/2024490,400 shares $6.99 million +4.2%8.3%16.8 $14.25
11/15/2024470,700 shares $5.91 million -2.9%8.0%15.4 $12.56
10/31/2024484,600 shares $6.52 million -3.3%8.2%16.3 $13.45
10/15/2024501,200 shares $7.10 million +1.1%8.5%16.3 $14.16
9/30/2024495,700 shares $7.12 million -1.9%8.4%14.8 $14.37
9/15/2024505,200 shares $7.54 million +8.3%8.5%10.9 $14.93
8/31/2024466,600 shares $6.54 million +3.3%7.9%9.8 $14.02
8/15/2024451,700 shares $6.13 million +8.7%7.8%10 $13.58
7/31/2024415,600 shares $6.70 million +12.1%7.3%9.2 $16.12
7/15/2024370,600 shares $5.80 million +42.4%6.5%8.2 $15.66
6/30/2024260,200 shares $4.49 million +13.4%4.6%5.7 $17.26
6/15/2024229,400 shares $3.39 million +17.6%4.1%6.8 $14.76
5/31/2024195,100 shares $2.89 million +10.2%3.3%5.2 $14.83
5/15/2024177,100 shares $2.61 million -6.4%3.0%4.1 $14.75
4/30/2024189,100 shares $2.35 million +2.2%3.2%3.6 $12.42
4/15/2024185,100 shares $2.64 million +31.7%3.2%3.6 $14.26
3/31/2024140,500 shares $2.80 million +2.5%2.4%2.9 $19.94
3/15/2024137,100 shares $2.40 million +13.0%2.4%3 $17.50
2/29/2024121,300 shares $1.48 million -30.1%2.1%3.2 $12.16
2/15/2024173,600 shares $2.01 million +12.4%3.0%5.5 $11.60
1/31/2024154,500 shares $1.33 million -4.2%2.6%8.1 $8.64
1/15/2024161,200 shares $1.49 million +5.8%2.8%9.2 $9.26
12/31/2023152,300 shares $1.60 million +32.8%2.6%9.5 $10.52
12/15/2023114,700 shares $1.23 million -31.3%2.0%7.9 $10.76
11/30/2023167,000 shares $1.95 million +0.1%2.9%11.6 $11.70
11/15/2023166,800 shares $1.83 million +2.0%2.9%12.4 $10.98
10/31/2023163,500 shares $1.37 million -11.3%2.8%12.7 $8.36
10/15/2023184,300 shares $1.59 million -5.5%3.1%13.8 $8.64
9/30/2023195,100 shares $1.72 million +0.1%3.3%14.2 $8.84
9/15/2023194,900 shares $1.76 million +7.9%3.3%12.8 $9.04
8/31/2023180,700 shares $1.66 million -3.4%3.1%10.2 $9.17
8/15/2023187,000 shares $1.99 million +5.2%3.2%9.4 $10.66
7/31/2023177,800 shares $1.64 million -4.6%3.0%8.6 $9.20
7/15/2023186,300 shares $1.74 million -4.7%3.2%7.8 $9.34
6/30/2023195,500 shares $1.89 million -12.7%3.3%5.2 $9.65
6/15/2023224,000 shares $2.47 million -1.0%3.8%5.5 $11.04
5/31/2023226,200 shares $2.46 million -6.5%6.3%5.5 $10.89
5/15/2023242,000 shares $2.72 million -21.7%6.8%5.6 $11.25
4/30/2023308,900 shares $3.31 million -9.2%8.6%6.7 $10.71
4/15/2023340,000 shares $4.02 million +23.3%9.5%6.9 $11.81
3/31/2023275,700 shares $3.80 million +43.2%7.7%6.3 $13.79
3/15/2023192,500 shares $2.49 million +9.9%5.4%4.7 $12.92
2/28/2023175,100 shares $2.73 million -1.1%4.9%4.4 $15.61
2/15/2023177,100 shares $2.98 million -2.2%4.9%4.1 $16.85
Trump’s EO to send this $5 stock ripping higher…? (Ad)

President Trump's December executive order declared space a national security and economic priority, fueling a race among SpaceX, Blue Origin, and others to build massive satellite constellations. One tiny firm holds the patented tech required to transmit satellite data to Earth at scale - and it reportedly powers SpaceX's most profitable division. Shares trade for under 5 dollars. Former JPMorgan wealth manager Ross Givens says it's the most uniquely positioned stock he's seen in 20 years of trading.tc pixel

Get the full free report on this overlooked space stock now
1/31/2023181,100 shares $3.59 million -9.8%5.0%4 $19.84
1/15/2023200,800 shares $3.27 million -10.6%5.6%4.5 $16.26
12/30/2022224,600 shares $3.41 million +15.6%6.2%5.3 $15.20
12/15/2022194,300 shares $2.52 million -17.8%5.4%5 $12.97
11/30/2022236,400 shares $3.30 million +0.2%6.6%5.5 $13.95
11/15/2022235,900 shares $2.61 million +26.5%6.6%5.8 $11.08
10/31/2022186,500 shares $1.68 million -21.6%5.2%4.4 $9.01
10/15/2022238,000 shares $2.35 million -10.6%6.6%4.9 $9.86
9/30/2022266,200 shares $2.42 million +3.5%24.0%1.2 $9.10
9/15/2022257,100 shares $2.66 million +10.6%23.2%1.1 $10.35
8/31/2022232,400 shares $2.20 million +19.5%18.3%0.9 $9.48
8/15/2022194,500 shares $2.02 million -34.6%15.1%0.6 $10.39
7/31/2022297,200 shares $2.40 million -29.0%23.0%1 $8.09
7/15/2022418,400 shares $3.87 million +59.8%32.4%1.3 $9.24
6/30/2022261,800 shares $2.22 million -28.7%20.3%1.8 $8.47
6/15/2022367,000 shares $2.98 million +5.6%10.1%2.8 $8.12
5/31/2022347,500 shares $2.69 million +12.7%11.3%3.2 $7.74
5/15/2022308,400 shares $2.99 million +3.4%10.1%4.4 $9.69
4/30/2022298,300 shares $3.53 million +8.9%9.7%4.4 $11.85
4/15/2022273,900 shares $4.70 million -14.3%3.1%4 $17.16
3/31/2022319,500 shares $6.27 million +59.8%3.6%4.9 $19.62
3/15/2022200,000 shares $4.27 million +7.2%2.2%2.6 $21.33
2/28/2022186,500 shares $3.63 million +1.3%2.0%2.5 $19.49
2/15/2022184,200 shares $3.55 million +25.7%2.0%2.6 $19.26
1/31/2022146,500 shares $2.71 million +67.2%1.6%2.5 $18.47
1/15/202287,600 shares $1.77 million -18.4%N/A1.7 $20.24
12/31/2021107,300 shares $2.61 million -2.7%1.2%2.4 $24.33
12/15/2021110,300 shares $2.91 million +3.6%1.1%2.8 $26.36
11/30/2021106,500 shares $3.35 million +24.9%3.9%3.2 $31.43

GLSI Short Interest - Frequently Asked Questions

Short interest is the volume of Greenwich LifeSciences shares that have been sold short but have not yet been closed out or covered. As of October 30th, investors have sold 1,578,166 shares of GLSI short. 22.07% of Greenwich LifeSciences' shares are currently sold short. Learn More on Greenwich LifeSciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GLSI shares currently have a short interest ratio of 12.5. Learn More on Greenwich LifeSciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.07% of Greenwich LifeSciences' floating shares are currently sold short.

Greenwich LifeSciences saw an increase in short interest since the prior report. As of October 30th, there was short interest totaling 1,578,166 shares, an increase of 1.7% from the previous total of 1,552,366 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

22.07% of Greenwich LifeSciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Greenwich LifeSciences: Pharming Group N.V. Sponsored ADR (0.04%), Aktis Oncology (8.23%), MeiraGTx Holdings PLC (7.47%), Oric Pharmaceuticals, Inc. (10.98%), Monte Rosa Therapeutics, Inc. (26.12%), Immatics N.V. (2.68%), Lexicon Pharmaceuticals, Inc. (6.76%), Syndax Pharmaceuticals, Inc. (22.08%), Alumis Inc. (12.86%), Rigel Pharmaceuticals, Inc. (15.31%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.66 billion), Invesco QQQ ($57.17 billion), iShares Russell 2000 ETF ($21.91 billion), SPDR S&P Biotech ETF ($10.53 billion), Union Pacific Corporation ($9.26 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.05 billion), Nebius Group N.V. ($7.85 billion), iShares 20+ Year Treasury Bond ETF ($7.81 billion), Moderna, Inc. ($7.36 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.20 billion). View all of the most shorted stocks.

Short selling GLSI is an investing strategy that aims to generate trading profit from Greenwich LifeSciences as its price is falling. GLSI shares are trading down $1.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Greenwich LifeSciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLSI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLSI, twice per month. The most recent reporting period available is October, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like GLSI:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:GLSI is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 11/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners